4.2 Article

Long-Term Maintenance of Cardiorespiratory Fitness Gains After Cardiac Rehabilitation Reduces Mortality Risk in Patients With Multimorbidity

出版社

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/HCR.0000000000000734

关键词

cardiac rehabilitation; cardiorespiratory fitness; mortality; multimorbidity

向作者/读者索取更多资源

The study aimed to investigate the impact of multimorbidity and cardiorespiratory fitness on mortality in patients completing cardiac rehabilitation. The results showed that improving cardiorespiratory fitness can reduce the risk of death, while the presence of other noncommunicable diseases does not have a significant effect on mortality rates.
Purpose:The objective of this study was to characterize the impact of multimorbidity and cardiorespiratory fitness (CRF) on mortality in patients completing cardiac rehabilitation (CR). Methods:This cohort study included data from patients with a history of cardiovascular disease (CVD) completing a 12-wk CR program between January 1996 and March 2016, with follow-up through March 2017. Patients were stratified by the presence of multimorbidity, which was defined as having a diagnosis of >= 2 noncommunicable diseases (NCDs). Cox regression analyses were used to evaluate the effects of multimorbidity and CRF on mortality in patients completing CR. Symptom-limited exercise tests were completed at baseline, immediately following CR (12 wk), with a subgroup completing another test at 1-yr follow-up. Peak metabolic equivalents (METs) were determined from treadmill speed and grade. Results:Of the 8320 patients (61 +/- 10 yr, 82% male) included in the analyses, 5713 (69%) patients only had CVD diagnosis, 2232 (27%) had CVD+1 NCD, and 375 (4%) had CVD+>= 2 NCDs. Peak METs at baseline (7.8 +/- 2.0, 6.9 +/- 2.0, 6.1 +/- 1.9 METs), change in peak METs immediately following CR (0.98 +/- 0.98, 0.83 +/- 0.95, 0.76 +/- 0.95 METs), and change in peak METs 1 yr after CR (0.98 +/- 1.27, 0.75 +/- 1.17, 0.36 +/- 1.24 METs) were different (P < .001) among the subgroups. Peak METs at 12 wk and the presence of coexisting conditions were each predictors (P < .001) of mortality. Improvements in CRF by >= 0.5 METS from baseline to 1-yr follow-up among patients with or without multimorbidity were associated with lower mortality rates. Conclusion:Increasing CRF by >= 0.5 METs improves survival regardless of multimorbidity status.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.2
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据